Chart, page-6

My research shows me this is an exceptionally promising opportunity the company has. Feels like the products and the market have lined up exceptionally well for success... but now they have to do it. Could be a really interesting few months to see if they can land a licensing deal now that the FDA approvals are landing.
I hated the price action last week...no doubt a stain on the company - but that's what you get when you play with regal. I definitely don't think it's overprices in the mid 2's - so anyone caught in this will hopefully not be deeply under water for long, especially if they can produce another volume driving announcement in the short term.
I see plenty of opportunity for this to be above 5c in the next 6 months and I am planning on adding to my holdings at these levels (which i don't think will present for more than a week or so, if that).